SarahE.(Janes)LandDO

Clinical Trials

• A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3) Start of enrollment: 2021 Aug 27

  Recruiting

  Phase 3

• A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease Start of enrollment: 2022 Jun 02

  Active, not recruiting

  Phase 3

• Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome Start of enrollment: 2021 Sep 13

  Recruiting

  Phase 3

• Memory Improvement Through Nicotine Dosing (MIND) Study Start of enrollment: 2017 Jan 13

  Active, not recruiting

  Phase 2

• Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS Start of enrollment: 2018 Nov 09

  Enrolling by invitation

  Phase 2, Phase 3

• AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid Start of enrollment: 2020 Jul 14

  Recruiting

  Phase 3

• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) Start of enrollment: 2021 May 18

  Active, not recruiting

  Phase 3

• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) Start of enrollment: 2021 May 18

  Active, not recruiting

  Phase 3

• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) Start of enrollment: 2020 Jun 19

  Active, not recruiting

  Phase 3

• Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28

  Completed

  Phase 3

• Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder Start of enrollment: 2020 Dec 22

  Recruiting

  Phase 3

• Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder Start of enrollment: 2021 Mar 30

  Enrolling by invitation

  Phase 3

• Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study Start of enrollment: 2015 Sep 08

  Completed

• A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease Start of enrollment: 2022 Aug 15

  Recruiting

  Phase 2

• A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD) Start of enrollment: 2020 May 22

  Terminated

  Phase 3

• Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects Start of enrollment: 2021 Mar 01

  Completed

  Phase 2

• Join now to see all